Abstract
Atrial fibrillation (AF) is prevalent and there is a clinical need for biomarkers to identify individuals at higher risk for AF. Fixed throughout a life course and assayable early in life, genetic biomarkers may meet this need. Here, we investigate whether multiple single nucleotide polymorphisms together as an AF genetic risk score (AF-GRS) can improve prediction of one's risk for AF.
Original language | English |
---|---|
Pages (from-to) | 2856 |
Journal | Stroke: a journal of cerebral circulation |
Volume | 45 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2014 |
Subject classification (UKÄ)
- Neurology